Abbott Laboratories vs. BridgeBio Oncology Therapeutics, Inc. Common Stock
ABT
Abbott Laboratories
$106.20 +1.56%
VS BBOTBridgeBio Oncology Therapeutics, Inc. Common Stock
$2.70 -3.57%
Abbott Laboratories and BridgeBio Oncology Therapeutics, Inc. Common Stock are evenly matched on the factors we track — the better pick depends on what you're optimizing for.
Size & Scale
| ABT | BBOT | |
|---|---|---|
| Market Cap | $180.95 billion | $224.49 million |
ABT leads on 1 of 1 size & scale factors.
Dividend
| ABT | BBOT | |
|---|---|---|
| Dividend Yield | 2.37% | — |
ABT and BBOT split the dividend factors evenly.
Risk & Sentiment
| ABT | BBOT | |
|---|---|---|
| Short Interest | 0.57% | 0.05% |
BBOT leads on 1 of 1 risk & sentiment factors.
Dig deeper: ABT overview, ABT financials, BBOT overview, BBOT financials.
Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.